Andrew D. Gribble

865 citations

20 papers · 674 indexed · h-index 14

Co-authors: Pieter H.E. Groot Ian T. Forbes Robert J. Ife Neil Pearce Theo A. Berkhout John Yates David G. Tew Jason Witherington
Topics: Neurotransmitter Receptor Influence on Behavior (5 papers)Cancer, Lipids, and Metabolism (4 papers)Lipoproteins and Cardiovascular Health (3 papers)
Cited by: Cellular and Molecular Neuroscience Cancer Research Biological Psychiatry
Journals: Biochemical Journal Journal of Medicinal Chemistry British Journal of Pharmacology
Partner nations: United Kingdom United States

In The Last Decade

Andrew D. Gribble

20 papers receiving 646 citations

Peers

Countries citing papers authored by Andrew D. Gribble

Since Specialization

Citations

This map shows the geographic impact of Andrew D. Gribble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew D. Gribble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew D. Gribble more than expected).

Fields of papers citing papers by Andrew D. Gribble

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew D. Gribble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew D. Gribble. The network helps show where Andrew D. Gribble may publish in the future.

Co-authorship network of co-authors of Andrew D. Gribble

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew D. Gribble. A scholar is included among the top collaborators of Andrew D. Gribble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew D. Gribble. Andrew D. Gribble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacological Profile of Antipsychotics at Monoamine Receptors: Atypicality Beyond 5-HT2A Receptor Blockade 2006 ·CNS & Neurological Disorders - Drug Targets ·Martyn Wood,Claire M. Scott,(unknown),(unknown),Nisha Patel,(unknown),Angela Worby,Laurie Gordon,(unknown),Graham J. Riley,Ceri H. Davies,Andrew D. Gribble,Declan N.C. Jones	30
2	Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties 2006 ·European Journal of Pharmacology ·Martyn Wood,Claire M. Scott,(unknown),(unknown),Ceri H. Davies,Charlie Reavill,(unknown),Claire Rourke,(unknown),Declan N.C. Jones,Ian T. Forbes,Andrew D. Gribble	45
3	SB‐656104‐A, a novel selective 5‐HT₇ receptor antagonist, modulates REM sleep in rats 2003 ·British Journal of Pharmacology ·David R. Thomas,Sergio Melotto,(unknown),Andrew D. Gribble,Philip D. Jeffrey,Alexander J. Stevens,Nigel Deeks,Peter Eddershaw,(unknown),Graham J. Riley,Tania O. Stean,Claire M. Scott,Matthew Hill,Derek N. Middlemiss,Jim J. Hagan,Gary Price,Ian T. Forbes	101
4	Identification of a novel series of selective 5-HT7 receptor antagonists 2003 ·Bioorganic & Medicinal Chemistry Letters ·Ian T. Forbes,David G. Cooper,(unknown),(unknown),Andrew D. Gribble,Robert J. Ife,Andrew P. Lightfoot,(unknown),(unknown),Tanya Coleman,Graham J. Riley,David R. Thomas	16
5	ATP-citrate Lyase: A Potential Target for Hypolipidemic Intervention 2003 ·Pieter H.E. Groot,Neil Pearce,Andrew D. Gribble	12
6	CCR2: Characterization of the Antagonist Binding Site from a Combined Receptor Modeling/Mutagenesis Approach 2003 ·Journal of Medicinal Chemistry ·Theo A. Berkhout,Frank E. Blaney,Angela Bridges,David G. Cooper,Ian T. Forbes,Andrew D. Gribble,Pieter H.E. Groot,A. Hardy,Robert J. Ife,Rejbinder Kaur,Kitty Moores,(unknown),(unknown),Jason Witherington	75
7	SB-656104-A: A novel 5-HT7 receptor antagonist with improved In vivo properties 2002 ·Bioorganic & Medicinal Chemistry Letters ·Ian T. Forbes,(unknown),Andrew D. Gribble,Robert J. Ife,Andrew P. Lightfoot,(unknown),Graham J. Riley,Philip D. Jeffrey,Alexander J. Stevens,Tania O. Stean,David R. Thomas	59
8	Targeted replacement of rodent CCR2 with the human orthologue CCR2B: A mouse model for in vivo analysis of human target‐selective small molecule MCP‐1 receptor antagonists 2002 ·Drug Development Research ·Haydn M. Prosser,David G. Cooper,Ian T. Forbes,Martin Geppert,Andrew D. Gribble,Evelyn Grau,Pieter H.E. Groot,Alex Harper,Kitty Moores,Susan J. Pickering,Valerie Piercy	8
9	Conformationally Restricted Indolopiperidine Derivatives as Potent CCR2B Receptor Antagonists 2001 ·Bioorganic & Medicinal Chemistry Letters ·Jason Witherington,Vincent Bordas,(unknown),Ian T. Forbes,Andrew D. Gribble,Robert J. Ife,Theo A. Berkhout,(unknown),Pieter H.E. Groot	35
10	Solid-phase synthesis of cyclic alkoxyketones, inhibitors of the cysteine protease cathepsin K 2001 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),Andrew D. Gribble,Robert J. Ife,(unknown),Jason Witherington	14
11	Diastereoselective synthesis, activity and chiral stability of cyclic alkoxyketone inhibitors of cathepsin K 2001 ·Bioorganic & Medicinal Chemistry Letters ·Ashley Fenwick,Andrew D. Gribble,Robert J. Ife,(unknown),Jason Witherington	13
12	Cyclic Ketone Inhibitors of the Cysteine Protease Cathepsin K 2001 ·Journal of Medicinal Chemistry ·Robert W. Marquis,Yu Ru,Jin Zeng,Robert E. Lee Trout,(unknown),Andrew D. Gribble,Jason Witherington,Ashley Fenwick,(unknown),Thaddeus A. Tomaszek,David G. Tew,Mark E. Hemling,Chad Quinn,Ward W. Smith,Baoguang Zhao,Michael S. McQueney,Cheryl A. Janson,Karla D'Alessio,Daniel F. Veber	42
13	The inhibition of human cytomegalovirus (hCMV) protease by hydroxylamine derivatives 1999 ·Bioorganic & Medicinal Chemistry Letters ·David G. Smith,Andrew D. Gribble,David Haigh,Robert J. Ife,(unknown),(unknown),Brian P. Slingsby,(unknown),Robert W. Ward,Andrew B. West	14
14	ChemInform Abstract: ATP‐Citrate Lyase as a Target for Hypolipidemic Intervention. Part 2. Synthesis and Evaluation of (3R,5S)‐ω‐Substituted‐3‐carboxy‐3,5‐dihydroxyalkanoic Acids and Their γ‐Lactone Prodrugs as Inhibitors of the Enzyme in vitro and in vivo. 1999 ·ChemInform ·Andrew D. Gribble,(unknown)	1
15	ATP-Citrate Lyase as a Target for Hypolipidemic Intervention. 2. Synthesis and Evaluation of (3R,5S)-ω-Substituted-3-carboxy-3,5-dihydroxyalkanoic Acids and Their γ-Lactone Prodrugs as Inhibitors of the Enzyme in Vitro and in Vivo 1998 ·Journal of Medicinal Chemistry ·Andrew D. Gribble,Robert J. Ife,Antony N. Shaw,(unknown),(unknown),(unknown),(unknown),Roland E. Dolle,Pieter H.E. Groot,Neil Pearce,John Yates,David G. Tew,Helen Boyd,Stephen Ashman,Drake S. Eggleston,R. Curtis Haltiwanger,George Okafo	26
16	The role of ATP citrate-lyase in the metabolic regulation of plasma lipids 1998 ·Biochemical Journal ·Neil Pearce,John Yates,Theo A. Berkhout,Brian Jackson,David G. Tew,Helen Boyd,Patrick Camilleri,Patricia J. Sweeney,Andrew D. Gribble,Anthony N. Shaw,Pieter H.E. Groot	124
17	Apolipoprotein E3-Leiden transgenic mice as a test model for hypolipidaemic drugs. 1998 ·PubMed* ·Bart J. van Vlijmen,Neil Pearce,Martin O. Bergö,Bart Staels,John Yates,Andrew D. Gribble,Brian Bond,M H Hofker,(unknown),Pieter H.E. Groot	28
18	ATP-Citrate Lyase as a Target for Hypolipidemic Intervention. Design and Synthesis of 2-Substituted Butanedioic Acids as Novel, Potent Inhibitors of the Enzyme 1996 ·Journal of Medicinal Chemistry ·Andrew D. Gribble,Roland E. Dolle,Antony N. Shaw,(unknown),Riccardo Novelli,(unknown),Brian P. Slingsby,(unknown),David G. Tew,Barbara Saxty,Mark S. Allen,Pieter H.E. Groot,Neil Pearce,John Yates	29
19	A fluorine-19 NMR study of interactions between the ATP-citrate lyase inhibitor SB-200517 and model membranes 1995 ·Chemistry and Physics of Lipids ·David G. Reid,(unknown),David G. Tew,Andrew D. Gribble	1
20	Reactions of αω-dodecatrienediylnickel with dimethyl acetylenedicarboxylate and methyl propiolate 1978 ·Journal of the Chemical Society Perkin Transactions 1 ·Raymond Baker,(unknown),R. C. Cookson,(unknown),Andrew D. Gribble	1

About Andrew D. Gribble

Andrew D. Gribble is a scholar working on Cancer Research, Cellular and Molecular Neuroscience and Microbiology, having authored 20 papers that have together received 674 indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (5 papers), Cancer, Lipids, and Metabolism (4 papers) and Lipoproteins and Cardiovascular Health (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (177 citations), Cancer Research (129 citations) and Biological Psychiatry (16 citations). Andrew D. Gribble has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Pieter H.E. Groot, Ian T. Forbes, Robert J. Ife, Neil Pearce, Theo A. Berkhout, John Yates, David G. Tew, Jason Witherington, Graham J. Riley and Helen Boyd. Their work appears in journals such as Biochemical Journal, Journal of Medicinal Chemistry and British Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact